Andrykowski M A, Altmaier E M, Barnett R L, Burish T G, Gingrich R, Henslee-Downey P J
Department of Behavioral Science, University of Kentucky College of Medicine, Lexington 40536-0086.
Bone Marrow Transplant. 1990 Oct;6(4):269-76.
Bone marrow transplant (BMT) patients are exposed to several potential sources of neurologic damage including the neurotoxicity of pre-BMT preparative regimens. The latter generally include a combination of total body irradiation (TBI) and high-dose chemotherapy. Cognitive functioning in 30 adult allogeneic BMT patients (mean of 47 months post-BMT) treated for either acute or chronic leukemia was assessed by two standardized self-report questionnaires. Consistent with hypothesis, results of both univariate and multivariate analyses indicated that increased dose of TBI was associated with increased cognitive dysfunction. Furthermore, this relationship remained even after the impact of psychological distress upon cognitive functioning was accounted for. TBI-related cognitive impairment primarily involved slowed reaction time, reduced attention and concentration, and difficulties in reasoning and problem-solving. These results complement previous findings of an inverse association between dose of TBI and self-perceptions of health and physical functioning in BMT survivors and indicate the importance of including quality of life measures in clinical trials of therapeutic innovations in the field of BMT.
骨髓移植(BMT)患者面临多种潜在的神经损伤来源,包括BMT预处理方案的神经毒性。后者通常包括全身照射(TBI)和大剂量化疗的联合应用。通过两份标准化的自我报告问卷,对30例接受急性或慢性白血病治疗的成年异基因BMT患者(BMT后平均47个月)的认知功能进行了评估。与假设一致,单变量和多变量分析结果均表明,TBI剂量增加与认知功能障碍增加相关。此外,即使在考虑了心理困扰对认知功能的影响之后,这种关系仍然存在。与TBI相关的认知障碍主要表现为反应时间延长、注意力和专注力下降,以及推理和解决问题困难。这些结果补充了先前关于BMT幸存者中TBI剂量与健康和身体功能自我认知之间负相关的研究发现,并表明在BMT领域治疗创新的临床试验中纳入生活质量测量的重要性。